Bayer AG (BSE:BAYN) Momentum Rank : 0 (As of May. 06, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Bayer AG Momentum Rank?

Bayer AG has the Momentum Rank of 0.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Bayer AG Momentum Rank Related Terms

Thank you for viewing the detailed overview of Bayer AG's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Bayer AG (BSE:BAYN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (BSE:BAYN) » Definitions » Momentum Rank

Comparable Companies

Traded in Other Exchanges

BAYZF:USA BAYRY:USA BAY:Poland BAYN:Mexico BAY:Italy BAYER:Hungary 0P6S:UK BAYNd:UK BAYN:Germany BAYN:Austria

Address

Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368

Website

https://www.bayer.com

Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.

Bayer AG (BSE:BAYN) Headlines

From GuruFocus

Market Indexes Lower as Market Considers Outlook

By Julie Young Julie Young • 05-23-2016

Oakmark International Fund Buys Bayer AG, Roche Holding AG, Fresenius Medical Care AG. KGaA, Sells BNP Paribas, Baidu Inc, CNH Industrial NV

By GuruFocus Research GuruFocus Editor • 03-01-2021

Analysts Think Bayer Shares Have Huge Upside

By Barry Cohen Barry Cohen • 03-04-2019

Oakmark International Fund Buys Fresenius Medical Care AG. KGaA, Anheuser-Busch InBev SA/NV, Bayer AG, Sells NAVER Corp, Daimler AG, Valeo SA

By GuruFocus Research GuruFocus Editor • 11-30-2020

David Herro Comments on Bayer

By Holly LaFon Holly LaFon • 04-06-2018

Bayer AG Expects Currency to Ding Earnings by $191.5 Million

By Jacob Maslow Jacob Maslow • 05-21-2018